Chargement de la page
Logo of D.E.S is it, DES Action group in France (Diethylstilbestrol)

News of the DES scandal

Prenatal diethylstilbestrol exposure and risk of diabetes, gallbladder disease, and pancreatic disorders and malignancies

Effects of in utero diethylstilbestrol exposure on the pancreas

DES (diethylstilbestrol) is a synthetic estrogen and notorious endocrine disruptor synthesized in 1938 by a group of English scientists led by E.C. Dodds. It has been marketed in many countries by different pharmaceutical companies, mainly to prevent miscarriage and prematurity risks in pregnant women.

In France, DES was prescribed und...

Read more
Several cases of clear cell adenocarcinoma (CCAC) reported in DES granddaughters (diethylstilbestrol)

Several cases of Clear Cell Adenocarcinoma (CCA) in DES Granddaughters (diethylstilbestrol)

Diethylstilbestrol (DES) has been marketed in many countries by several pharmaceutical companies under different brand names. It has been widely prescribed to pregnant women to prevent miscarriages.

Thanks to a study by W.J. Dieckmann, it was known, as early as 1953 that this treatment was ineffective in pregnant women for all its indi...

Read more
Portrait of depressed and sick man suffering from psychosis illness or mental disorder - DES (diethylstilbestrol ) exposure and psychiatric disorder, autism Asperger

Exposure to Diethylstilbestrol: mental illness and neurodevelopmental disorders in descendants

In France, diethylstilbestrol (DES) was prescribed to approximately 200,000 pregnant women between 1948 (sometimes before) and its ban in 1977 (sometimes after), under the brand names Distilbène®, Stilboestrol-Borne® and Furostilboestrol®, to prevent miscarriages and premature births.

We don't hear much about it ...

Read more
Spinner - ADHD - attention-deficit hyperactivity disorder - diethylstilbestrol - consequences of DES - diethylstilbestrol

Exposure to Diethylstilbestrol (DES) linked to Attention Deficit Hyperactivity Disorder (ADHD) in Third Generation

Diethylstilbestrol (or DES – a commonly used abbreviation) is a well-known endocrine disruptor. In France, it has been marketed under the brand names Distilbène®, Stilboestrol-Borne® and Furostilboestrol®.

It was mainly prescribed to pregnant women between 1948 and 1977, where it was banned. Its main indication...

Read more
Russian doll (matriochka) - D.E.S Exposure - The Diethylstilbestrol Legacy

Prenatal DES exposure also induces malformations of the external genitalia in the third generation

Diethylstilbestrol, known as DES – marketed in France under the brand names Distilbène® and Stilboestrol-Borne®, is one of the most well studied endocrine disruptor to date. It is a nonsteroidal synthetic estrogen, teratogenic, carcinogenic and genotoxic.

Heralded as a medical miracle for preventing miscarriage and...

Read more